These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

342 related items for PubMed ID: 10909973

  • 1. Glucagon-like peptide 1 stimulates insulin gene promoter activity by protein kinase A-independent activation of the rat insulin I gene cAMP response element.
    Skoglund G, Hussain MA, Holz GG.
    Diabetes; 2000 Jul; 49(7):1156-64. PubMed ID: 10909973
    [Abstract] [Full Text] [Related]

  • 2. Exendin-4 as a stimulator of rat insulin I gene promoter activity via bZIP/CRE interactions sensitive to serine/threonine protein kinase inhibitor Ro 31-8220.
    Chepurny OG, Hussain MA, Holz GG.
    Endocrinology; 2002 Jun; 143(6):2303-13. PubMed ID: 12021195
    [Abstract] [Full Text] [Related]

  • 3. Over-expression of the glucagon-like peptide-1 receptor on INS-1 cells confers autocrine stimulation of insulin gene promoter activity: a strategy for production of pancreatic beta-cell lines for use in transplantation.
    Chepurny OG, Holz GG.
    Cell Tissue Res; 2002 Feb; 307(2):191-201. PubMed ID: 11845326
    [Abstract] [Full Text] [Related]

  • 4. Synergistic effect of dimethyl sulfoxide on glucagon-like peptide 1 (GLP-1)-stimulated insulin secretion and gene transcription in INS-1 cells: characterization and implications.
    Kemp DM, Habener JF.
    Biochem Pharmacol; 2002 Aug 15; 64(4):689-97. PubMed ID: 12167488
    [Abstract] [Full Text] [Related]

  • 5. Insulinotropic hormone glucagon-like peptide 1 (GLP-1) activation of insulin gene promoter inhibited by p38 mitogen-activated protein kinase.
    Kemp DM, Habener JF.
    Endocrinology; 2001 Mar 15; 142(3):1179-87. PubMed ID: 11181533
    [Abstract] [Full Text] [Related]

  • 6. NFAT regulates insulin gene promoter activity in response to synergistic pathways induced by glucose and glucagon-like peptide-1.
    Lawrence MC, Bhatt HS, Easom RA.
    Diabetes; 2002 Mar 15; 51(3):691-8. PubMed ID: 11872668
    [Abstract] [Full Text] [Related]

  • 7. Glucagon-like peptide-1 stimulates human insulin promoter activity in part through cAMP-responsive elements that lie upstream and downstream of the transcription start site.
    Hay CW, Sinclair EM, Bermano G, Durward E, Tadayyon M, Docherty K.
    J Endocrinol; 2005 Aug 15; 186(2):353-65. PubMed ID: 16079261
    [Abstract] [Full Text] [Related]

  • 8. Glucagon-like peptide-1 causes pancreatic duodenal homeobox-1 protein translocation from the cytoplasm to the nucleus of pancreatic beta-cells by a cyclic adenosine monophosphate/protein kinase A-dependent mechanism.
    Wang X, Zhou J, Doyle ME, Egan JM.
    Endocrinology; 2001 May 15; 142(5):1820-7. PubMed ID: 11316746
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Desensitization and phosphorylation of the glucagon-like peptide-1 (GLP-1) receptor by GLP-1 and 4-phorbol 12-myristate 13-acetate.
    Widmann C, Dolci W, Thorens B.
    Mol Endocrinol; 1996 Jan 15; 10(1):62-75. PubMed ID: 8838146
    [Abstract] [Full Text] [Related]

  • 11. Glucagon-like peptide-1 improves insulin and proinsulin binding on RINm5F cells and human monocytes.
    Ebinger M, Jehle DR, Fussgaenger RD, Fehmann HC, Jehle PM.
    Am J Physiol Endocrinol Metab; 2000 Jul 15; 279(1):E88-94. PubMed ID: 10893327
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Transfection of pancreatic-derived beta-cells with a minigene encoding for human glucagon-like peptide-1 regulates glucose-dependent insulin synthesis and secretion.
    Hui H, Yu R, Bousquet C, Perfetti R.
    Endocrinology; 2002 Sep 15; 143(9):3529-39. PubMed ID: 12193567
    [Abstract] [Full Text] [Related]

  • 14. Glucagon-like peptide 1 elevates cytosolic calcium in pancreatic beta-cells independently of protein kinase A.
    Bode HP, Moormann B, Dabew R, Göke B.
    Endocrinology; 1999 Sep 15; 140(9):3919-27. PubMed ID: 10465260
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Glucagon-like peptide-1 inhibits apoptosis of insulin-secreting cells via a cyclic 5'-adenosine monophosphate-dependent protein kinase A- and a phosphatidylinositol 3-kinase-dependent pathway.
    Hui H, Nourparvar A, Zhao X, Perfetti R.
    Endocrinology; 2003 Apr 15; 144(4):1444-55. PubMed ID: 12639928
    [Abstract] [Full Text] [Related]

  • 17. Exendin-4 induction of cyclin D1 expression in INS-1 beta-cells: involvement of cAMP-responsive element.
    Kim MJ, Kang JH, Park YG, Ryu GR, Ko SH, Jeong IK, Koh KH, Rhie DJ, Yoon SH, Hahn SJ, Kim MS, Jo YH.
    J Endocrinol; 2006 Mar 15; 188(3):623-33. PubMed ID: 16522741
    [Abstract] [Full Text] [Related]

  • 18. Glucagon-like peptide-1 affects gene transcription and messenger ribonucleic acid stability of components of the insulin secretory system in RIN 1046-38 cells.
    Wang Y, Egan JM, Raygada M, Nadiv O, Roth J, Montrose-Rafizadeh C.
    Endocrinology; 1995 Nov 15; 136(11):4910-7. PubMed ID: 7588224
    [Abstract] [Full Text] [Related]

  • 19. Somatostatin inhibits glucagon-like peptide-1-induced insulin secretion and proliferation of RINm5F insulinoma cells.
    Stark A, Mentlein R.
    Regul Pept; 2002 Oct 15; 108(2-3):97-102. PubMed ID: 12220732
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.